The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gender disparities in Waldenstrom macroglobulinemia: Insights from a comprehensive analysis.
 
David Kaldas
No Relationships to Disclose
 
Shrinjaya Thapa
No Relationships to Disclose
 
Bushra Shariff
No Relationships to Disclose
 
Shrikar Modukuri
No Relationships to Disclose
 
Kenneth H. Shain
Honoraria - Amgen; Bristol Myers Squibb (Celgene); GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; GlaxoSmithKline; Janssen Oncology
Speakers' Bureau - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen Oncology; Sanofi; Takeda
Research Funding - Abbvie; Karyopharm Therapeutics
 
Brandon Jamaal Blue
Honoraria - Abbvie; Janssen Oncology; Kite, a Gilead company; Oncopeptides; Pfizer
Consulting or Advisory Role - Janssen
Speakers' Bureau - Sanofi
 
Julio C. Chavez
Honoraria - Adaptive Biotechnologies; Lilly
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; Allogene Therapeutics; AstraZeneca; BMSi; Cellectar; Genmab; Janssen; Kite/Gilead; Novartis; TeneoBio
Speakers' Bureau - Epizyme
Research Funding - Adaptive Biotechnologies; AstraZeneca; Merck (Inst)
 
Rachid C. Baz
Honoraria - Hikma Pharmaceuticals
Consulting or Advisory Role - BMS; Janssen; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Arvinas (I); BMS (Inst); Daiichi Sankyo/Lilly (I); Janssen (Inst); Karyopharm Therapeutics (Inst); Marker Therapeutics (I); Pionyr (I); Quantum Leap Healthcare Collaborative (I); Regeneron (I); Seagen (I); Zymeworks (I)
Other Relationship - GlaxoSmithKline
 
Ariel Felipe Grajales-Cruz
Consulting or Advisory Role - Cellectar; Sanofi
Speakers' Bureau - Amgen; Sanofi